DNAe
PrivateLast Round
Grant
Sep 30, 2016
Total Funding Raised
$113.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
DNAe is a biotechnology company that develops a semiconductor-based, point-of-need next-generation sequencing platform for rapid infectious disease and oncology diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Semiconductors, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DNAe Comparables
Compare DNAe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenomeKey | 81% | |
| HelixBind | 80% | |
| Scanogen Inc. | 78% |
DNAe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2016 | ||||
| Debt | Nov 2, 2015 | ||||
| Corporate Funding | Jan 15, 2015 | ||||
| Early Funding | Apr 27, 2014 |
Key People
Founding team and executive leadership
DNAe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 114% MoM, reaching 1.7K.
- Apr 16, 2026
Monthly visitors increased 31% MoM, from 6.2K to 8.2K.
DNAe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DNAe's valuation, stock price, and market status.
Is DNAe a public or private company?
DNAe is a private company.
What is the current stock price of DNAe?
DNAe is a private company with no public stock price. No recent secondary market data is available.
How much is DNAe worth (valuation)?
Valuation information for DNAe is not publicly available.
Can I buy DNAe stock?
DNAe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DNAe's last funding round?
DNAe's most recent funding round was Grant on September 30, 2016.
Who are the main investors in DNAe?
Key investors in DNAe include Public Health Emergency Medical Countermeasures Enterprise.
Will DNAe IPO soon?
No public IPO plans have been announced for DNAe.
How can I track DNAe secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DNAe's secondary market activity and sign up for updates.